RSV Treatment

ReViral Raises $44 Million in Series C Financing    Yahoo Finance

ReViral Raises $44M in Series C Financing    FinSMEs

Ballad: Masks mandates helping in fight against COVID-19    Erwin Record

Reviral closes $44m Series C round to tackle respiratory syncytial virus    Business Weekly

Analysis | The Keys to Speed in Race for Vaccine, and Its Perils    Washington Post

Flu season could make US coronavirus testing delays even worse    bdnews24.com

Pediatric Respiratory Syncytial Virus ( RSV) Prophylactics Market Size 2020 | Brief Analysis by Top Companies – AstraZeneca, Novavax, Company 3, Company 4, Company 5    Scientect

Coronavirus creates a flu season guessing game    Science

Park County Coronavirus Testing Availability Dwindles    Cowboy State Daily

Coronavirus vs flu and colds: How symptoms compare to Covid-19    Telegraph.co.uk

Cepheid Xpert® Flu/RSV and Seegene Allplex™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice    Wiley

Flu's Added CV Risk Shows Need to Distinguish It From COVID-19    Medscape

Flu's Added CV Risk Shows Need to Distinguish It From COVID-19    Medscape

Intravacc's candidate RSV vaccine demonstrates safety in phase I trial | Vaccines | News Channels    PipelineReview.com

Social distancing decreased paediatric respiratory tract infections in Finland    EurekAlert

Respiratory syncytial virus seropositivity at birth is associated with adverse neonatal respiratory outcomes    MD Linx

Questions remain about airborne transmission of COVID-19    Healio

Park County Coronavirus Testing Availability Dwindles    Cowboy State Daily

Is It Too Early to Get Your Flu Shot?    Healthline

Coronavirus creates a flu season guessing game    Science

Coronavirus creates a flu season guessing game    Science

Is It Too Early to Get Your Flu Shot?    Healthline

Is It Too Early to Get Your Flu Shot?    Healthline

Wits University begins South African trial of Novavax COVID-19 vaccine    News-Medical.Net

Wits screens volunteers for second Covid-19 vaccine trial    Independent Online

Analysis | The Keys to Speed in Race for Vaccine, and Its Perils    Washington Post

Cleveland doctors and experts say Russia’s rush for vaccine poses risk for country’s population    cleveland.com

Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis.    Physician's Weekly

7 items every COVID-conscious family needs to prepare for flu season, according to medical experts    Yahoo Lifestyle

Novavax (NASDAQ:NVAX) Releases Quarterly Earnings Results, Beats Estimates By $0.30 EPS    MarketBeat

RSV Diagnostics Market to Witness Growth Acceleration During 2019-2026    Owned

RSV Diagnostics Market to Witness Growth Acceleration During 2019-2026    Owned

Video Highlights Social Distancing Challenges in Schools    NBC 5 Dallas-Fort Worth

Aridis Pharmaceuticals Announces Second Quarter 2020 Results | News    WFMZ Allentown

Why You Should Be Skeptical of Russian COVID-19 Vaccine Claims    Healthline

A potential method to stop pneumonia in babies    Northcliff Melville Times

A potential method to stop pneumonia in babies    Northcliff Melville Times

Nirsevimab Shows Promise in Preventing RSV Infections in Preterm-Born Infants    MD Magazine

Recent Studies of Global Pediatric Respiratory Syncytial Virus ( RSV) Prophylactics Market Forecast says Healthy Pick Up in CAGR By 2020-2027 | Companies like AstraZeneca, Novavax, Company 3, Company 4, Company 5    Red & Black Student Newspaper

Nirsevimab Shows Promise in Preventing RSV Infections in Preterm-Born Infants    MD Magazine

Aridis Pharmaceuticals Announces Second Quarter 2020 Results    PRNewswire

Why You Should Be Skeptical of Russian COVID-19 Vaccine Claims    Healthline

Russia's Coronavirus Vaccine Is Not a 'Sputnik Moment'    American Council on Science and Health

I'm an Infectious Disease Doctor and Have This Warning for Fall    MSN Money

Sisunatovir Fast-Tracked for Serious RSV Infection    Monthly Prescribing Reference

Tangen Biosciences Closes Oversubscribed $12.2M Series B Preferred Stock Financing    Business Wire

Tangen Biosciences Closes Oversubscribed $12.2M Series B Preferred Stock Financing    Valdosta Daily Times

Why Do Babies Pretend To Cough? Experts Explain    Romper

Tangen Biosciences Closes Oversubscribed $12.2M Series B Preferred Stock Financing    Business Wire

J&J Wins $1B US Contract for SARS-CoV-2 Vax    Contract Pharma

Progress In Pharma's Slow Battle Against Respiratory Syncytial Virus    Scrip

New RSV treatment could be a game changer, Dutch researcher says    NL Times

Respiratory viruses in pediatric emergency department patients and their family members    Wiley

AstraZeneca Nirsevimab Data, And Other News: The Good, Bad And Ugly Of Biopharma    Seeking Alpha

NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK    360Dx

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2020 with Webcast and Conference Call Today at 4:30 pm ET    BioSpace

Bavarian Nordic Announces the Launch of Distribution and Marketing of RabAvert® in the US Supported by a US Commercial Team    BioSpace

NHS Will Roll Out COVID-19 Tests From DNANudge, Oxford Nanopore Across UK    GenomeWeb

Clinical Catch-Up: July 27-31    BioSpace

Clinical Catch-Up: July 27-31    BioSpace

AstraZeneca Nirsevimab Data, And Other News: The Good, Bad And Ugly Of Biopharma    Seeking Alpha

AstraZeneca Nirsevimab Data, And Other News: The Good, Bad And Ugly Of Biopharma    Seeking Alpha

Respiratory Syncytial Virus Diagnostics Market Current Scenario Analysis with Forecast by 2029    BioSpace

Duke's decision to reopen could cost lives    Duke Chronicle

Government orders 5.8 million rapid COVID-19 tests | Imperial News    Imperial College London

New data in NEJM shows nirsevimab reduced respiratory syncytial virus infections (lower respiratory tract infections) requiring medical care in health    PharmiWeb.com

Respiratory Syncytial Virus Diagnostics Market Current Scenario Analysis with Forecast by 2029    BioSpace

AstraZeneca Nirsevimab Data, And Other News: The Good, Bad And Ugly Of Biopharma    Seeking Alpha

Government orders 5.8 million rapid COVID-19 tests | Imperial News    Imperial College London

RSV Diagnostics Market Size By Top Leading Key Players, Growth Opportunities, Incremental Revenue , Trends, Outlook And Forecasts    Market Research Posts

All About EIDD-2801 | Elemental    Elemental

AstraZeneca Nirsevimab Data, And Other News: The Good, Bad And Ugly Of Biopharma    Seeking Alpha